Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma

Diverse Biotech announces orphan-drug designation for treatment of newly diagnosed glioblastoma

DOYLESTOWN, Pa., May 4, 2020 /PRNewswire/ — Diverse Biotech, Inc. www.diversebiotech.com has announced the U.S. Food & Drug Administration (FDA) has granted an orphan-drug designation request fo…
Read More

Leave a Reply

Your email address will not be published. Required fields are marked *